Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Opinion & Analysis (GREY:ATBPF)

    Buzz on the Bullboards: PyroGenesis, Antibe Top All Sectors

    Omri Wallach June 18, 2020

    Buzz on the Bullboards: Healthcare Falls, Cannabis and Energy Rise

    Omri Wallach June 11, 2020

    Buzz on the Bullboards: Stocks Poised for Coronavirus Recovery?

    Omri Wallach February 27, 2020

    Buzz on the Bullboards: The Rebound Season?

    Omri Wallach December 5, 2019

    Top Pick Status Given to Small-Cap with Pain Drug Candidate

    Streetwise Reports July 19, 2019

    Buzz on the Bullboards: Investing Success in 2019?

    Stockhouse Editorial January 11, 2019

    Canadian Biopharma to Outlicense Pain Drug to South Korean Firm

    Streetwise Reports September 13, 2018

    Buzz on the Bullboards: NEW Favorites Grabbing Attention

    Stockhouse Editorial March 23, 2018

    Fund Manager Names Three Small-Caps with Strong Growth Profiles

    Streetwise Reports February 23, 2018

    VIDEO: Safe Medicine for Pain and Inflammation

    BTV-Business Television September 12, 2017

    VIDEO: Game Changing Pain Relief

    BTV-Business Television September 12, 2017

    Five companies with favorable risk/reward profiles from the AlphaNorth Capital Conference

    The Life Sciences Report April 13, 2017

    Good news for all companies in the Athabasca Basin

    Stockhouse Editorial August 10, 2015

    Why I’m bullish on China hoarding gold and hiding it secretly

    Stockhouse Editorial July 21, 2015

    Premier says Alberta on track for surplus despite low oil $

    Stockhouse Editorial February 24, 2015